PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BIOPX vs. BIAGX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BIOPX and BIAGX is 0.87, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.


-0.50.00.51.00.9

Performance

BIOPX vs. BIAGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Baron Opportunity Fund (BIOPX) and Brown Advisory Growth Equity Fund (BIAGX). The values are adjusted to include any dividend payments, if applicable.

-40.00%-30.00%-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
13.13%
-44.11%
BIOPX
BIAGX

Key characteristics

Sharpe Ratio

BIOPX:

1.20

BIAGX:

-0.80

Sortino Ratio

BIOPX:

1.65

BIAGX:

-0.68

Omega Ratio

BIOPX:

1.22

BIAGX:

0.75

Calmar Ratio

BIOPX:

0.99

BIAGX:

-0.66

Martin Ratio

BIOPX:

5.86

BIAGX:

-1.90

Ulcer Index

BIOPX:

4.58%

BIAGX:

20.84%

Daily Std Dev

BIOPX:

22.50%

BIAGX:

49.52%

Max Drawdown

BIOPX:

-67.79%

BIAGX:

-59.64%

Current Drawdown

BIOPX:

-6.83%

BIAGX:

-59.24%

Returns By Period

In the year-to-date period, BIOPX achieves a 2.52% return, which is significantly higher than BIAGX's 0.61% return. Over the past 10 years, BIOPX has outperformed BIAGX with an annualized return of 9.77%, while BIAGX has yielded a comparatively lower -1.92% annualized return.


BIOPX

YTD

2.52%

1M

-2.93%

6M

13.14%

1Y

23.68%

5Y*

13.73%

10Y*

9.77%

BIAGX

YTD

0.61%

1M

-4.59%

6M

-44.12%

1Y

-41.33%

5Y*

-9.28%

10Y*

-1.92%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BIOPX vs. BIAGX - Expense Ratio Comparison

BIOPX has a 1.31% expense ratio, which is higher than BIAGX's 0.81% expense ratio.


BIOPX
Baron Opportunity Fund
Expense ratio chart for BIOPX: current value at 1.31% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.31%
Expense ratio chart for BIAGX: current value at 0.81% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.81%

Risk-Adjusted Performance

BIOPX vs. BIAGX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BIOPX
The Risk-Adjusted Performance Rank of BIOPX is 6666
Overall Rank
The Sharpe Ratio Rank of BIOPX is 6464
Sharpe Ratio Rank
The Sortino Ratio Rank of BIOPX is 6363
Sortino Ratio Rank
The Omega Ratio Rank of BIOPX is 6565
Omega Ratio Rank
The Calmar Ratio Rank of BIOPX is 6666
Calmar Ratio Rank
The Martin Ratio Rank of BIOPX is 7171
Martin Ratio Rank

BIAGX
The Risk-Adjusted Performance Rank of BIAGX is 00
Overall Rank
The Sharpe Ratio Rank of BIAGX is 00
Sharpe Ratio Rank
The Sortino Ratio Rank of BIAGX is 11
Sortino Ratio Rank
The Omega Ratio Rank of BIAGX is 00
Omega Ratio Rank
The Calmar Ratio Rank of BIAGX is 00
Calmar Ratio Rank
The Martin Ratio Rank of BIAGX is 00
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BIOPX vs. BIAGX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Baron Opportunity Fund (BIOPX) and Brown Advisory Growth Equity Fund (BIAGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BIOPX, currently valued at 1.20, compared to the broader market-1.000.001.002.003.004.001.20-0.80
The chart of Sortino ratio for BIOPX, currently valued at 1.65, compared to the broader market0.002.004.006.008.0010.0012.001.65-0.68
The chart of Omega ratio for BIOPX, currently valued at 1.22, compared to the broader market1.002.003.004.001.220.75
The chart of Calmar ratio for BIOPX, currently valued at 0.99, compared to the broader market0.005.0010.0015.0020.000.99-0.66
The chart of Martin ratio for BIOPX, currently valued at 5.86, compared to the broader market0.0020.0040.0060.0080.005.86-1.90
BIOPX
BIAGX

The current BIOPX Sharpe Ratio is 1.20, which is higher than the BIAGX Sharpe Ratio of -0.80. The chart below compares the historical Sharpe Ratios of BIOPX and BIAGX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
1.20
-0.80
BIOPX
BIAGX

Dividends

BIOPX vs. BIAGX - Dividend Comparison

Neither BIOPX nor BIAGX has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BIOPX vs. BIAGX - Drawdown Comparison

The maximum BIOPX drawdown since its inception was -67.79%, which is greater than BIAGX's maximum drawdown of -59.64%. Use the drawdown chart below to compare losses from any high point for BIOPX and BIAGX. For additional features, visit the drawdowns tool.


-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-6.83%
-59.24%
BIOPX
BIAGX

Volatility

BIOPX vs. BIAGX - Volatility Comparison

Baron Opportunity Fund (BIOPX) has a higher volatility of 6.40% compared to Brown Advisory Growth Equity Fund (BIAGX) at 3.73%. This indicates that BIOPX's price experiences larger fluctuations and is considered to be riskier than BIAGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%SeptemberOctoberNovemberDecember2025February
6.40%
3.73%
BIOPX
BIAGX
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab